tiprankstipranks
Trending News
More News >
Verastem (VSTM)
NASDAQ:VSTM

Compare Verastem (VSTM) vs. Competitors

Compare
1,957 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Verastem
$7.87
$575.44M
-1.85
33.39%
6 Buy
0 Hold
0 Sell
Strong Buy
Cardiff Oncology
$3.17
$216.23M
-3.99
-18.82%
6 Buy
0 Hold
0 Sell
Strong Buy
Mereo Biopharma Group Plc
$0.38
$67.11M
-1.46
-89.79%
6 Buy
2 Hold
0 Sell
Strong Buy
Monopar Therapeutics Inc
$63.40
$434.43M
-18.44
159.20%
11 Buy
0 Hold
0 Sell
Strong Buy
Silence Therapeutics
$5.80
$273.96M
-3.47
-8.52%
2 Buy
0 Hold
0 Sell
Moderate Buy
Atea Pharmaceuticals
$3.61
$271.88M
-2.03
8.08%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VSTM
Verastem
7.87
2.14
37.35%
CRDF
Cardiff Oncology
3.17
-0.44
-12.19%
MREO
Mereo Biopharma Group Plc
0.38
-3.17
-89.18%
MNPR
Monopar Therapeutics Inc
63.40
38.05
150.10%
SLN
Silence Therapeutics
5.80
-0.19
-3.17%
AVIR
Atea Pharmaceuticals
3.61
0.34
10.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts